Table 4 |
||
|
Causes of Death of Participants with Prior Heart Failure Hospitalization |
||
|
Chlorthalidone Treatment Group |
Doxazosin Treatment Group |
|
|
|
||
|
No. of participants with hospitalization for heart failure prior to death* |
280 |
317 |
|
No. of deaths (%) |
52 (18.6) |
70 (22.1) |
|
Cause of death (%) |
||
|
Myocardial infarction |
7 (13.5) |
5 (7.1) |
|
Definite CHD |
5 (9.6) |
9 (12.9) |
|
Possible CHD |
1 (1.9) |
7 (10.0) |
|
Stroke |
1 (1.9) |
3 (4.3) |
|
Heart failure |
11 (21.2) |
12 (17.1) |
|
Other CVD |
4 (7.7) |
7 (10.0) |
|
Total cardiovascular deaths (%) |
29 (55.8) |
43 (61.4) |
|
Cancer |
8 (15.4) |
6 (8.6) |
|
Kidney disease |
1 (1.9) |
1 (1.4) |
|
Accident/suicide/homicide |
0 (0) |
1 (1.4) |
|
Other non-CVD |
8 (15.4) |
11 (15.7) |
|
Unknown |
6 (11.5) |
8 (11.4) |
|
|
||
|
CHD = Coronary heart disease CVD = Cardiovascular disease *Excludes participants for whom death is the first reported heart failure event |
||
|
Piller et al. Current Controlled Trials in Cardiovascular Medicine 2002 3:10 doi:10.1186/1468-6708-3-10 |
||
